PULMONX CORPORATION (LUNG) Total liabilities 2019–2025
PULMONX CORPORATION (LUNG) total liabilities at each fiscal year-end, per SEC filings.
$75.2MFY2025 · since FY2019: $35.6M → $75.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.2M | -2.4% |
| FY2024 | $77.0M | +29.6% |
| FY2023 | $59.5M | +49.9% |
| FY2022 | $39.7M | -5.4% |
| FY2021 | $41.9M | +11.6% |
| FY2020 | $37.6M | +5.6% |
| FY2019 | $35.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross profitLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Shareholders’ equityLUNG overview →